Â鶹´«Ã½Ó³»­

Â鶹´«Ã½Ó³»­

Explore the latest content from across our publications
Join The Â鶹´«Ã½Ó³»­

Log In

Forgot Password?
Create New Account

Loading... please wait

2024 Annual Meeting | C53 - Status Epilepticus Update

Sunday 04/14/24
01:00 PM - 03:00 PM MDT Add To Calendar
This program will be presented both in-person and online
This program will be available in the meeting's On Demand product.
Seminar
Clio A. Rubinos, MD, MSCR
Epilepsy/Clinical Neurophysiology (EEG)
Participants should comprehend the pathophysiological rationale for administering essential early-stage medications to prevent the progression of status epilepticus; recognize and address various types and phases of status epilepticus, including NORSE; and develop an approach to managing challenging EEG patterns such as periodic discharges and the ictal-interictal continuum.
 
This program is supported in part by an educational grant from Marinus Pharmaceuticals, Inc.
2.00 CME credits
Patient Care & Procedural Skills, Interpersonal and Communication Skills, Medical Knowledge, Practice-based Learning and Improvement, Systems-based Practice, Quality Improvement
Intermediate
Neurohospitalist
Fellow, Resident, General Neurologist, Specialist Neurologist, Non-neurologist, Advanced Practice Provider, Neurohospitalist, Medical Student
Case-based, Didactic, Audience Participation
Event Timeline
01:00 PM - 01:05 PM MDT Introduction Introduction
Clio A. Rubinos, MD, MSCR
01:05 PM - 01:30 PM MDT Speaker Status Epilepticus: The Golden Hour Treatment
LUIS O. CABOCLO, MD, PhD
01:30 PM - 01:55 PM MDT Speaker Refractory and Super Refractory Status Epilepticus: What Can We Do?
Clio A. Rubinos, MD, MSCR
01:55 PM - 02:20 PM MDT Speaker Periodic and Rhythmic Patterns: When to Treat and How?
Suzette M. LaRoche, MD, FÂ鶹´«Ã½Ó³»­
02:20 PM - 02:30 PM MDT Q&A Questions and Answers
Suzette M. LaRoche, MD, FÂ鶹´«Ã½Ó³»­
02:30 PM - 02:40 PM MDT Speaker Patient Experience Sharing Video
Clio A. Rubinos, MD, MSCR
02:40 PM - 03:00 PM MDT Discussion Interactive Game—Status Patronus: How Would You Treat This Status Epilepticus Patient? With Panel Commentary
Clio A. Rubinos, MD, MSCR, Suzette M. LaRoche, MD, FÂ鶹´«Ã½Ó³»­
Faculty Disclosures
Clio A. Rubinos, MD, MSCR Dr. Rubinos has nothing to disclose.
Suzette M. LaRoche, MD, FÂ鶹´«Ã½Ó³»­ Dr. LaRoche has received intellectual property interests from a discovery or technology relating to health care. Dr. LaRoche has received publishing royalties from a publication relating to health care. Dr. LaRoche has a non-compensated relationship as a President with American Clinical Neurophysiology Society that is relevant to Â鶹´«Ã½Ó³»­ interests or activities.
LUIS O. CABOCLO, MD, PhD Dr. CABOCLO has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. CABOCLO has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Libbs Phamaceutical. Dr. CABOCLO has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for UCB. Dr. CABOCLO has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Adium Pharmaceutical. Dr. CABOCLO has received personal compensation in the range of $0-$499 for serving as an officer or member of the Board of Directors for Endogen Pharmaceutical (Brazil). Dr. CABOCLO has stock in Endogen Pharmaceutical (Brazil).